Now I have a thorough understanding of the paper and the reviews. Let me produce the final consolidated review.

## Summary

This paper proposes CLAD, a contrastive learning-based method for multi-class anomaly detection. The approach uses a frozen feature extractor, an MLP-based dimensionality reduction adaptor, and an MLP-based discriminator with classification capabilities. CLAD employs a two-stage training process: first, supervised contrastive learning with local and global anomaly synthesis (adapted from GLASS) to learn separable class representations; second, fine-tuning without the contrastive loss to enable larger batch sizes. Experiments on MVTec-AD and VisA report strong results against five baselines (UniAD, DRAEM, RD, SimpleNet, DiAD).

## Strengths

1. **Addresses an important and practical problem.** Multi-class anomaly detection (one model for all classes) is genuinely useful for industrial deployment and has received less attention than single-class AD. The paper's focus on a lightweight, discriminator-based architecture (MLPs only, no reconstruction network) is a well-motivated direction.

2. **Two-stage training with batch-size scaling is a practical innovation.** Disabling the contrastive loss in the second stage to jump from 8,000 to 100,000 patch features per batch (§3.5) is a simple but sensible solution to contrastive learning's batch-size bottleneck, and it is transparently described.

3. **Sensible synthesis strategy.** Adapting both local (DTD texture + Perlin masks) and global (gradient-ascent-guided Gaussian noise) anomaly synthesis from GLASS into a multi-class setting is a principled way to generate diverse negatives, and the paper acknowledges the source faithfully.

4. **Competitive headline numbers.** The reported results on MVTec-AD (97.5/97.0/96.0 mAUROCsp/px/PRO) and VisA (outperforming UniAD by +9.4 in mAUPROpx) are impressive, even accounting for the evaluation caveats below.

## Weaknesses

### Fatal
None. The core claims are potentially salvageable with better experimental methodology.

### Major

1. **Non-standard evaluation protocol (max-over-runs, no variance).** The paper states (§4.1): *"The models are evaluated ten times evenly for all methods, and the result corresponding to the maximum pixel-level mAU-ROC value is taken as the final result."* Reporting the **maximum** over runs rather than the mean (with standard deviation or confidence intervals) systematically inflates reported performance and makes it impossible to assess whether CLAD is reliably better than baselines. Even though baselines receive the same treatment, the absolute numbers are unverifiable and the headline "SOTA" claims rest on a biased estimator. This is not a formatting nitpick — it is a methodological flaw that must be corrected. The paper also provides no standard deviations anywhere, including for the ablation experiments.

2. **Incomplete baseline comparison for a SOTA claim.** The paper claims state-of-the-art performance but compares only five methods (UniAD, DRAEM, RD, SimpleNet, DiAD). The related work section discusses DiffusionAD, InTra, and AnoVit as relevant multi-class approaches, yet none appear in the experiments. The paper mentions that MUAD is a relatively new task and that some methods only report single-class results, but for a SOTA claim a more comprehensive comparison is needed — at minimum against DiffusionAD and any published multi-class variants of the methods discussed. As it stands, the central conclusion is insufficiently supported.

### Minor

3. **Unclear notation in the contrastive loss.** The contrastive loss (§3.4) computes $D_{mean}(i,j) = \|\mu_i - \mu_j\|_2$ and refers to "the Euclidean distance between their means," but $\mu_i$ is never explicitly defined in this context. (The variance-loss section later defines $\mu_i$ as a class mean vector, but the contrastive loss appears to operate at the sample-pair level, not the class level.) This makes the loss formulation ambiguous and hard to reproduce from the paper alone.

4. **Missing ablation of the two-stage design.** The paper switches off the contrastive loss in stage 2 for efficiency but provides no ablation comparing (a) full two-stage, (b) stage 1 only, (c) stage 2 only, or (d) contrastive loss kept throughout. Without this, the contribution of the two-stage design is asserted rather than demonstrated.

5. **Overclaimed novelty framing.** The conclusion claims to be *"the first to introduce a feature embedding-based discriminative approach into multi-class anomaly detection."* SimpleNet is already a discriminator-based method (albeit single-class) and GLASS uses feature-level synthesis that could be adapted to multi-class. While the paper's specific combination for multi-class is novel, this absolute claim would benefit from more careful qualification.

### Trivial

6. **Figure 2 caption error.** The caption labels the Encoder, Adaptor, and Discriminator all as $E_{\Phi}$, whereas the text uses $E_{\Phi}$, $A_{\phi}$, and $D_{\psi}$ respectively. This is a typographical artifact that should be corrected.

7. **"Unsupervised" terminology.** The paper repeatedly calls CLAD "unsupervised" while using class labels during training for the contrastive loss and classification head. Since no anomaly labels are used, this is conventional looseness in the AD community, but the paper should clarify the distinction (e.g., "class-conditional" or "label-efficient") to avoid misleading readers unfamiliar with this convention.

## Nice-to-Haves

- An ablation of the anomaly synthesis hyperparameters ($\beta$, $\alpha$, $r_1$, $r_2$) would strengthen the paper, though their values are inherited from GLASS with reasonable defaults.
- t-SNE or PCA visualizations of the adaptor output space (referenced in Figure 3 but hard to evaluate from the text alone) would directly support the claimed "clear inter-class boundaries and compact intra-class structures."
- Per-class breakdowns of performance would help identify whether CLAD performs uniformly across categories or relies on a few well-behaved classes.

## Removed Points

- **Batch size criticism.** The reviewer claimed that batch sizes of 8,000 and 100,000 patch features are "memory-prohibitive." Patch features are low-dimensional vectors after MLP reduction; storing 100,000 such vectors (~50 MB at 128 dimensions) is negligible on dual 3090 GPUs (48 GB total). This reflects a misunderstanding of what "patch features" are, not a real issue.
- **Formatting and style nitpicks** about table captions, metric notation, and garbled text. Per the review guidelines, these are parser artifacts, not author errors.
- **Missing appendix / broken references.** Per the review guidelines, the parser strips these sections from all papers; they exist in the original submission.

## Novel Insights

Beyond the paper's own contributions, the most interesting signal from the reviews is the tension between two views of the paper: on one hand, the method combines well-understood components (contrastive learning, anomaly synthesis, MLP discriminator) in a way that produces strong results on a challenging and practically relevant task. On the other hand, the evaluation methodology — specifically the decision to report max-over-runs instead of mean ± std — undermines the quantitative evidence to the point where the paper's core claim (SOTA) is not verifiable from the presented data. This pattern is common in AD papers: the community has not converged on strict reproducibility standards, and papers that inflate results via non-standard protocols can initially appear strong. The meta-reviewer's job is to flag that the emperor has no clothes — not because the idea is bad, but because the evidence is presented in a way that prevents the reader from judging its true quality.

## Suggestions

1. **Replace max-over-runs with mean ± std over at least 5 random seeds** for all metrics and all methods. This is non-negotiable for the paper to be credible.
2. **Add at least 2-3 more baselines** relevant to multi-class AD (e.g., DiffusionAD, AnoVit, or a multi-class variant of EfficientAD). If these are not reproducible from their public code, explain why and acknowledge the limitation in the text.
3. **Clarify the contrastive loss notation:** define $\mu_i$ explicitly (is it the feature vector of sample $i$, the class-conditional mean, or something else?).
4. **Add an ablation table** comparing the two-stage design against simpler alternatives (single-stage with contrastive, single-stage without, etc.).
5. **Tone down the "first" claim** or qualify it more carefully. The method is novel in its specific combination for multi-class AD, but discriminative feature-embedding approaches to AD are not new.

## Score and Decision

**Calibration anchors** (all from the provided calibration corpus):

| Path | Human Score | Comparison to this paper |
|------|-------------|-------------------------|
| /home/.../Zzs3JwknAY.md (One-for-All Few-Shot AD) | 6.40 (Accept) | Stronger clarity and evaluation rigor; fewer methodological flaws. CLAD is weaker. |
| /home/.../AHgc5SMdtd.md (MuSc, Zero-Shot) | 5.20 (Accept) | Comparable contribution level, but MuSc has a cleaner evaluation and clearer exposition. CLAD has a more concerning evaluation flaw. |
| /home/.../R03zKO9T9S.md (ADer Benchmark) | 4.75 (Reject) | Similar weakness on missing std deviations. ADer has less novelty but more comprehensive evaluation. CLAD is comparable. |
| /home/.../bwVV0rHwrb.md (FBFT) | 4.50 (Reject) | Both have limited baselines and some methodological concerns. CLAD addresses a more practical problem setting. Comparable quality. |
| /home/.../isHiGhFwVV.md (Context Contrasting) | 4.50 (Reject) | Both have evaluation concerns. CLAD's results are stronger but its evaluation flaw is more severe. Similar tier. |
| /home/.../Vi6p2TeujL.md (PTAD) | 4.25 (Reject) | Both have issues with evaluation statistics and clarity. CLAD is slightly more interesting from a problem-setting perspective. |
| /home/.../jQnXDGxdDG.md (FIRM) | 3.80 (Reject) | FIRM has limited novelty; CLAD has a clearer practical motivation. CLAD is slightly better. |
| /home/.../MbtUctg3KW.md (Knowledge Exposure) | 2.50 (Reject) | This paper is substantially worse — poor writing, limited results. CLAD is clearly stronger. |

The paper addresses a relevant problem and proposes a reasonable method, but the evidence for its core claims is undermined by a fundamentally flawed evaluation protocol (max-over-runs, no variance reporting). Combined with an incomplete baseline comparison and several exposition issues, the paper in its current form does not provide a trustworthy basis for its stated conclusions. The ideas have merit and the path to remedy is clear (fix the evaluation, add baselines, clarify notation), but substantial revision is needed.

MY FINAL SCORE: 4.5
MY FINAL DECISION: Reject